J. Lindgren

497 total citations
20 papers, 397 citations indexed

About

J. Lindgren is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, J. Lindgren has authored 20 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in J. Lindgren's work include Glycosylation and Glycoproteins Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). J. Lindgren is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). J. Lindgren collaborates with scholars based in Finland, Sweden and United States. J. Lindgren's co-authors include Stig Nordling, Caj Haglund, Markku Seppälä, Peter Roberts‎, Pentti Kuusela, P. Sipponen, Ulf‐Håkan Stenman, Erkki Ruoslahti, E Saksela and Matti Seppälä and has published in prestigious journals such as The Lancet, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

J. Lindgren

20 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Lindgren Finland 12 132 119 91 87 72 20 397
Y Kawashima Japan 9 168 1.3× 61 0.5× 72 0.8× 60 0.7× 80 1.1× 43 489
Joan A. Stratton United States 9 65 0.5× 100 0.8× 74 0.8× 40 0.5× 30 0.4× 34 388
A. C. Jöbsis Netherlands 11 127 1.0× 63 0.5× 21 0.2× 107 1.2× 41 0.6× 18 483
Oluseyi A. Vanderpuye United States 12 176 1.3× 33 0.3× 33 0.4× 33 0.4× 35 0.5× 20 464
S Cohen United States 7 119 0.9× 58 0.5× 33 0.4× 22 0.3× 26 0.4× 14 434
U. K. Nässander Netherlands 9 95 0.7× 43 0.4× 108 1.2× 52 0.6× 52 0.7× 10 440
Liana De Vecchis Italy 13 188 1.4× 543 4.6× 57 0.6× 32 0.4× 92 1.3× 32 842
Venkateswara R. Naraparaju United States 12 174 1.3× 64 0.5× 26 0.3× 23 0.3× 32 0.4× 15 503
Feldman Jd United States 7 98 0.7× 28 0.2× 33 0.4× 49 0.6× 17 0.2× 19 322
P. R. Galbraith Canada 13 120 0.9× 128 1.1× 26 0.3× 19 0.2× 29 0.4× 29 506

Countries citing papers authored by J. Lindgren

Since Specialization
Citations

This map shows the geographic impact of J. Lindgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Lindgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Lindgren more than expected).

Fields of papers citing papers by J. Lindgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Lindgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Lindgren. The network helps show where J. Lindgren may publish in the future.

Co-authorship network of co-authors of J. Lindgren

This figure shows the co-authorship network connecting the top 25 collaborators of J. Lindgren. A scholar is included among the top collaborators of J. Lindgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Lindgren. J. Lindgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lindgren, J., et al.. (2001). Increased levels of somatostatin in rat ankles with adjuvant arthritis. Rheumatology International. 20(5). 186–191. 4 indexed citations
2.
Haglund, Caj, et al.. (1991). Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma. British Journal of Cancer. 63(3). 386–389. 25 indexed citations
3.
Haglund, Caj, J. Lindgren, PJ Roberts, Pentti Kuusela, & Stig Nordling. (1989). Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9. British Journal of Cancer. 60(6). 845–851. 40 indexed citations
4.
Karonen, S.-L., Hannu J. Aronen, K. Liewendahl, et al.. (1989). Localization of human malignant tumors with radioiodinated recombinant tissue plasminogen activator. Lung Cancer. 5(7). 25–25. 3 indexed citations
5.
Lindgren, J., Pentti Kuusela, P.-E. Hellström, Tom Pettersson, & Matti Klockars. (1988). The ovarian cancer associated antigen CA 125 in patients with pleural effusions. European Journal of Cancer and Clinical Oncology. 24(4). 737–739. 27 indexed citations
6.
Haglund, Caj, J. Lindgren, Peter Roberts‎, & Stig Nordling. (1986). Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis. British Journal of Cancer. 53(2). 189–195. 60 indexed citations
7.
Heikkilä, L, et al.. (1986). Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas.. PubMed. 75(5). 260–5. 2 indexed citations
8.
Lindgren, J., et al.. (1982). MONOCLONAL ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN (CEA): CHARACTERIZATION AND USE IN A RADIOIMMUNOASSAY FOR CEA. Acta Pathologica Microbiologica Scandinavica Series C Immunology. 90C(1-6). 159–162. 4 indexed citations
9.
Lindgren, J., et al.. (1982). Immunoperoxidase staining of carcinoembryonic antigen with monoclonal antibodies in adenocarcinoma of the colon. Histochemistry and Cell Biology. 74(2). 223–227. 4 indexed citations
10.
Ikonen, Riikka, et al.. (1980). ALPHA FETOPROTEIN LEVELS IN NEONATAL HYPERBILIRUBINAEMIA. Acta Paediatrica. 69(1). 59–63. 15 indexed citations
11.
Klockars, Matti, et al.. (1980). Carcinoembryonic antigen in pleural effusions: A diagnostic and prognostic indicator. European Journal of Cancer (1965). 16(9). 1149–1152. 19 indexed citations
12.
Lindgren, J., P. Sipponen, K. Seppälä, et al.. (1979). Carcinoembryonic antigen in endoscopic brush specimens from benign and malignant gastric lesions. British Journal of Cancer. 40(6). 848–855. 3 indexed citations
13.
Janunger, K. G., J. Lindgren, P. Sipponen, & L Domellöf. (1979). Carcinoembryonic Antigen (CEA) in the Gastric Mucosa after Partial Gastrectomy. Scandinavian Journal of Gastroenterology. 14(5). 555–560. 3 indexed citations
14.
Lindgren, J., Torsten Wahlström, & Markku Seppälä. (1979). Tissue CEA in premalignant epithelial lesions and epidermoid carcinoma of the uterine cervix: Prognostic significance. International Journal of Cancer. 23(4). 448–453. 28 indexed citations
15.
Rutanen, E.‐M., J. Lindgren, P. Sipponen, et al.. (1978). Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors.Circulating levels and tissue localization. Cancer. 42(2). 581–590. 66 indexed citations
16.
Westgren, U, Arne Melander, E. Wåhlin, & J. Lindgren. (1977). DIVERGENT EFFECTS OF 6-PROPYLTHIOURACIL ON 3,5,3′-TRIIODOTHYRONINE (T3) AND 3,3′,5′-TRIIODOTHYRONINE (RT3) SERUM LEVELS IN MAN. European Journal of Endocrinology. 85(2). 345–350. 11 indexed citations
17.
Aula, Perttì, O Karjalainen, Juhani Rapola, J. Lindgren, & Markku Seppälä. (1977). Prenatal diagnosis of the Meckel syndrome. American Journal of Obstetrics and Gynecology. 129(6). 700–702. 27 indexed citations
18.
Seppälä, Markku, O Karjalainen, Juhani Rapola, & J. Lindgren. (1976). MATERNAL ALPHA-FETOPROTEIN AND FETAL EXOMPHALOS. The Lancet. 307(7954). 303–304. 7 indexed citations
19.
Lindgren, J., Antti Vaheri, & Erkki Ruoslahti. (1974). Identification and Isolation of a Foetoprotein in the Chicken. Differentiation. 2(4). 233–236. 25 indexed citations
20.
Ahlborg, Ulf G., Bo Holmstedt, & J. Lindgren. (1968). Fate and Metabolism of Some Hallucinogenic Indolealkylamines. Advances in pharmacology. 6(Pt B). 213–229. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y Kawashima Breakdown of academic impact, for papers by Joan A. Stratton Breakdown of academic impact, for papers by A. C. Jöbsis Breakdown of academic impact, for papers by Oluseyi A. Vanderpuye Breakdown of academic impact, for papers by S Cohen Breakdown of academic impact, for papers by U. K. Nässander Breakdown of academic impact, for papers by Liana De Vecchis Breakdown of academic impact, for papers by Venkateswara R. Naraparaju Breakdown of academic impact, for papers by Feldman Jd Breakdown of academic impact, for papers by P. R. Galbraith
Rankless by CCL
2026